MedPath

Feasibility of skeletal muscle biopsy and near-infrared spectrometry in post-ICU patients: the Powerhouse feasibility study

Conditions
Post-Intensive Care Syndroom
Post-Intensive Care Syndrome
10047635
Recovery issues after Intensive Care admission
Registration Number
NL-OMON56670
Lead Sponsor
Ziekenhuisvoorzieningen Gelderse Vallei
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
5
Inclusion Criteria

1) >=18 years of age 2) Medical research council (MRC) sum score of at least 24
and less than 48 3) Serum haemoglobin of at least 5.0 mmol/L 4) BMI < 30 kg/m2
5) Admitted to an intensive care unit for at least 72 hours 6) exptected to be
discharged from the ICU within 48 hours 7) Written informed consent

Exclusion Criteria

1) Known mitochondrial disease
2) Pre-existent muscle disease
3) Diabetes Mellitus
4) Life expectancy less than 6 months
5) Visibly high melanin content in the skin
6) Subcutaneous fat layer > 3cm covering the GA muscle (measured by
ultrasound)
7) Coagulopathy (i.e. platelet count; < 50 x10 9 cells/ml, INR > 2.0 or recent
treatment with therapeutic dosage of low molecular weight heparin)
8) Recent lower extremity surgery
9) Delirium (defined as a delirium observation screening scale (DOS) of at
least three)
10) Deemed incompetent to provide well-considered informed consent by the
treating physician

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath